Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Receives $24.36 Average PT from Analysts

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) have received a consensus rating of “Reduce” from the fifteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a sell recommendation, nine have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $24.36.

WBA has been the topic of several recent analyst reports. TD Cowen decreased their target price on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a report on Wednesday, April 3rd. Truist Financial reiterated a “hold” rating and issued a $25.00 target price on shares of Walgreens Boots Alliance in a report on Monday, April 1st. TheStreet upgraded shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a report on Monday, January 8th. Morgan Stanley decreased their price objective on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating on the stock in a report on Monday, April 1st. Finally, Bank of America decreased their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a report on Tuesday, March 26th.

Insider Buying and Selling at Walgreens Boots Alliance

In related news, Director Inderpal S. Bhandari bought 3,000 shares of the company’s stock in a transaction that occurred on Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the transaction, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, CFO Manmohan Mahajan bought 6,000 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, April 2nd. The stock was bought at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the purchase, the chief financial officer now owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Inderpal S. Bhandari bought 3,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. In the last three months, insiders have bought 13,456 shares of company stock valued at $270,423. Insiders own 17.40% of the company’s stock.

Institutional Trading of Walgreens Boots Alliance

Several hedge funds and other institutional investors have recently made changes to their positions in WBA. Vanguard Group Inc. lifted its stake in shares of Walgreens Boots Alliance by 14.5% in the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock valued at $1,927,656,000 after purchasing an additional 10,962,030 shares during the period. Capital World Investors lifted its stake in shares of Walgreens Boots Alliance by 29.1% in the fourth quarter. Capital World Investors now owns 18,448,648 shares of the pharmacy operator’s stock valued at $481,694,000 after purchasing an additional 4,163,317 shares during the period. Invesco Ltd. lifted its stake in shares of Walgreens Boots Alliance by 21.5% in the third quarter. Invesco Ltd. now owns 17,026,420 shares of the pharmacy operator’s stock valued at $378,668,000 after purchasing an additional 3,013,807 shares during the period. Morgan Stanley lifted its stake in shares of Walgreens Boots Alliance by 15.8% in the third quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock valued at $279,876,000 after purchasing an additional 1,720,228 shares during the period. Finally, Norges Bank acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at about $29,816,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Down 0.9 %

NASDAQ WBA opened at $18.05 on Friday. The company has a market capitalization of $15.57 billion, a PE ratio of -2.58, a P/E/G ratio of 1.13 and a beta of 0.73. The company has a fifty day moving average of $20.26 and a 200 day moving average of $21.86. Walgreens Boots Alliance has a 1 year low of $17.51 and a 1 year high of $35.54. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. The business had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The company’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.16 earnings per share. Research analysts forecast that Walgreens Boots Alliance will post 3.23 earnings per share for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.